ArticleJournal of biomechanical engineering2026
In-Vitro Evaluations of Shape Memory Polymer Scaffolds With Tunable Architecture for the Endovascular Embolization of Unruptured Intracranial Aneurysms.
Article in Journal of biomechanical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Translationally relevant metrics for shape memory polymer (SMP) scaffolds intended for the endovascular treatment of intracranial aneurysms were evaluated in various in vitro experiments. Multiple SMP formulations were first evaluated for glass transition properties, with saturated scaffolds demonstrating Tg midpoints of 39 °C, 35 °C, and 32 °C, respectively. Then, the scaffold's porosity (85-95%) and infill pattern (rectilinear, honeycomb, gyroid) were varied, and these designs were systematically compared by compressibility, shape recovery (SR), and pulsatile compaction resistance. The compressibility of ideal and wide-necked aneurysm geometries, each in 6 mm and 8 mm diameter sizes, indicated an upper limit of ∼9 mm in treatable aneurysm diameter for a 5 French catheter. Under physiologically relevant pulsatile loading, all scaffold designs resisted notable compaction, with maximum deformation values not exceeding 55 μm. The shape recovery forces were primarily governed by the porosity level, with low- and medium-porosity scaffolds showing complete and reliable shape recovery, and high-porosity scaffolds exhibiting reduced completeness of shape recovery. Shape recovery rates varied both within and across infill pattern and porosity groups. Together, these findings provide quantitative benchmarks for the translational viability of our SMP scaffold in different key stages of device deployment and establish design guidelines for further optimization of patient-specific endovascular devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.